[The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy].
Kubori T, Mezaki T, Kaji R, Kimura J, Hamaguchi K, Hirayama K, Kanazawa I, Miyatake T, Mannen T, Kowa H, Yanagisawa N, Goto I, Osame M, Kanda M, Tashiro K, Baba M, Kuroiwa Y, Nagatomo H, Mitsuma T, Shigeta Y, Saida T, Nakajima K, Kawamura J, Murai Y, Kiuchi T, et al.
Kubori T, et al. Among authors: hamaguchi k.
No To Shinkei. 1999 Feb;51(2):127-35.
No To Shinkei. 1999.
PMID: 10198901
Clinical Trial.
Japanese.